Improvements in lung function, exercise, and quality of life in hypercapnic COPD patients after lung volume reduction surgery.

STUDY OBJECTIVE To determine the impact of preoperative resting hypercapnia on patient outcome after bilateral lung volume reduction surgery (LVRS). METHODS We prospectively examined morbidity, mortality, quality of life (QOL), and physiologic outcome, including spirometry, gas exchange, and exercise performance in 15 patients with severe emphysema and a resting PaCO2 of > 45 mm Hg (group 1), and compared the results with those from 31 patients with a PaCO2 of < 45 mm Hg (group 2). RESULTS All preoperative physiologic and QOL indices were more impaired in the hypercapnic patients than in the eucapnic patients. The hypercapnic patients exhibited a lower preoperative FEV1, a lower diffusing capacity of the lung for carbon monoxide, a lower ratio of PaO2 to the fraction of inspired oxygen, a lower 6-min walk distance, and higher oxygen requirements. However, after surgery both groups exhibited improvements in FVC (group 1, p < 0.01; group 2, p < 0.001), FEV1 (group 1, p=0.04; group 2, p < 0.001), total lung capacity (TLC; group 1, p=0.02; group 2, p < 0.001), residual volume (RV; group 1, p=0.002; group 2, p < 0.001), RV/TLC ratio (group 1, p=0.03; group 2, p < 0.001), PaCO2 (group 1, p=0.002; group 2, p=0.02), 6-min walk distance (group 1, p=0.005; group 2, p < 0.001), oxygen consumption at peak exercise (group 1, p=0.02; group 2, p=0.02), total exercise time (group 1, p=0.02; group 2, p=0.02), and the perceived overall QOL scores (group 1, p=0.001; group 2, p < 0.001). However, because the magnitude of improvement was similar in both groups, and the hypercapnic group was more impaired, the spirometry, lung volumes, and 6-min walk distance remained significantly lower post-LVRS in the hypercapnic patients. There was no difference in mortality between the groups (p=0.9). CONCLUSIONS Patients with moderate to severe resting hypercapnia exhibit significant improvements in spirometry, gas exchange, perceived QOL, and exercise performance after bilateral LVRS. The maximal achievable improvements in postoperative lung function are related to preoperative level of function; however, the magnitude of improvement can be expected to be similar to patients with lower resting PaCO2 levels. Patients should not be excluded from LVRS based solely on the presence of resting hypercapnia. The long-term benefit of LVRS in hypercapnic patient remains to be determined.

[1]  A. Fein,et al.  Lung volume reduction surgery: answering the crucial questions. , 1998, Chest.

[2]  K. Ellstrom Lung volume reduction surgery. , 1997, Critical care nurse.

[3]  M. Argenziano,et al.  Extended indications for lung volume reduction surgery in advanced emphysema. , 1996, The Annals of thoracic surgery.

[4]  N. Zamel,et al.  Lung function 12 months following emphysema resection. , 1996, Chest.

[5]  G. Patterson,et al.  Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. , 1996, The Journal of thoracic and cardiovascular surgery.

[6]  M. Hauser,et al.  Bilateral volume reduction surgery for diffuse pulmonary emphysema by video-assisted thoracoscopy. , 1996, The Journal of thoracic and cardiovascular surgery.

[7]  N. Zamel,et al.  Mechanism of short-term improvement in lung function after emphysema resection. , 1996, American journal of respiratory and critical care medicine.

[8]  D. O’Donnell,et al.  Mechanisms of relief of exertional breathlessness following unilateral bullectomy and lung volume reduction surgery in emphysema. , 1996, Chest.

[9]  P. E. Walters,et al.  Lung volume reduction surgery. Case selection, operative technique, and clinical results. , 1996, Annals of surgery.

[10]  R. Rogers,et al.  Improvement in pulmonary function and elastic recoil after lung-reduction surgery for diffuse emphysema. , 1996, The New England journal of medicine.

[11]  R. Mckenna,et al.  A randomized, prospective trial of stapled lung reduction versus laser bullectomy for diffuse emphysema. , 1996, The Journal of thoracic and cardiovascular surgery.

[12]  F. Sciurba,et al.  Unilateral thoracoscopic surgical approach for diffuse emphysema. , 1996, The Journal of thoracic and cardiovascular surgery.

[13]  J. Cooper,et al.  Comparison of early functional results after volume reduction or lung transplantation for chronic obstructive pulmonary disease. , 1996, The Journal of thoracic and cardiovascular surgery.

[14]  E. Trulock,et al.  Results of lung volume reduction surgery in patients with emphysema. The Washington University Emphysema Surgery Group. , 1996, Seminars in thoracic and cardiovascular surgery.

[15]  D. Wood Lung volume reduction surgery for severe emphysema. , 1996, Tecnologica.

[16]  R. Yusen,et al.  Evaluation of patients with emphysema for lung volume reduction surgery. Washington University Emphysema Surgery Group. , 1996, Seminars in thoracic and cardiovascular surgery.

[17]  J. Cooper,et al.  Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. , 1995, The Journal of thoracic and cardiovascular surgery.

[18]  A. Miller,et al.  Lung function testing: selection of reference values and interpretative strategies. , 1992, The American review of respiratory disease.

[19]  A. Grassino,et al.  Inspiratory muscle dysfunction and chronic hypercapnia in chronic obstructive pulmonary disease. , 1991, The American review of respiratory disease.

[20]  J. Milic-Emili,et al.  Intrinsic PEEP and arterial PCO2 in stable patients with chronic obstructive pulmonary disease. , 1990, The American review of respiratory disease.

[21]  A. Woolcock,et al.  Eucapnia and hypercapnia in patients with chronic airflow limitation. The role of the upper airway. , 1990, The American review of respiratory disease.

[22]  D. Johns,et al.  Single breath carbon monoxide diffusing capacity (transfer factor) , 1988, The American review of respiratory disease.

[23]  C. K. Mahutte,et al.  Hyperoxic-induced hypercapnia in stable chronic obstructive pulmonary disease. , 2015, The American review of respiratory disease.

[24]  D. F. Rochester,et al.  Determinants of maximal inspiratory pressure in chronic obstructive pulmonary disease. , 2015, The American review of respiratory disease.

[25]  N. Anthonisen,et al.  Familial aspects of ventilatory control in patients with chronic obstructive pulmonary disease. , 2015, The American review of respiratory disease.

[26]  C. Wells,et al.  The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. , 1984, Chest.

[27]  M. Bergner,et al.  The Sickness Impact Profile: Development and Final Revision of a Health Status Measure , 1981, Medical care.

[28]  J. Blum,et al.  Pattern of breathing and carbon dioxide retention in chronic obstructive lung disease. , 1981, The American journal of medicine.

[29]  N. Cherniack,et al.  Comparison of the respiratory responses to external resistive loading and bronchoconstriction. , 1981, The Journal of clinical investigation.

[30]  J. Milic-Emili,et al.  Breathing pattern and hypercapnia in patients with obstructive pulmonary disease. , 1980, The American review of respiratory disease.

[31]  J. Dempsey,et al.  Determinants of chronic carbon dioxide retention and its correction in humans. , 1980, The Journal of clinical investigation.

[32]  J. Weil,et al.  Hypoventilation in obstructive lung disease. The role of familial factors. , 1978, The New England journal of medicine.

[33]  A. Grassino,et al.  Control of breathing in patients with chronic obstructive lung disease. , 1978, Clinical science and molecular medicine.

[34]  M. Altose,et al.  Effects of hypercapnia and inspiratory flow-resistive loading on respiratory activity in chronic airways obstruction. , 1977, The Journal of clinical investigation.

[35]  J. Howell,et al.  Relation between Airways Obstruction and CO2 Tension in Chronic Obstructive Airways Disease , 1968, British medical journal.

[36]  R. V. Lourenço,et al.  Drive and performance of the ventilatory apparatus in chronic obstructive lung disease. , 1968, The New England journal of medicine.